Listen on the go
CORRECT!
Next question
touchINFECTIOUS DISEASES touchINFECTIOUS DISEASES

Start Learning

Touch Loading image
touchIN CONVERSATION
Start Learning
Selecting ART: Working with people living with HIV to find the best regimen
touchEXPERT OPINIONS
Start Learning
Demystifying virology: The link between the HIV life cycle and ART
JOURNALS
Start Learning
Study reveals significant decline in life expectancy in India during COVID-19
JOURNALS
Start Learning
Avoiding Multidrug Resistance in a Hospital Setting
JOURNALS
Start Learning
#ESCMIDGlobal2025: Dr Dariusz Hareza on antibiotic resistance beyond borders
JOURNALS
Start Learning
Coming soon! touchINFECTIOUS DISEASES Future Leaders 2025
HIV
JOURNALS
Start Learning
PURPOSE 1 & 2: lenacapavir safe and effective for HIV PrEP in young populations
JOURNALS
Start Learning
#ESCMIDGlobal2025 Insights: Key infectious disease updates clinicians shouldn’t miss
JOURNALS
Start Learning
ESCMID Global 2025 Young Investigator awardee Dr Simon Feys on ICU Medicine and Infectious Disease: touchINFECTIOUS DISEASES Future Leader 2025
JOURNALS
Start Learning
Dr Simon Feys on unmasking VAPA: Investigating fungal superinfections in viral pneumonia

to view Favourites, Keep Notes and Track CME Credits

Favourites
A warm welcome to Dr Dariusz Hareza joining our Editorial Board!
View
#ESCMIDGlobal2025 Insights: Key infectious disease updates clinicians shouldn’t miss
View
Dr Ikechukwu Benjamin Moses on phages and the promise of AI in antimicrobial resistance: touchINFECTIOUS DISEASES Future Leader 2025
View
Vaccinating children in endemic regions could be the most efficient strategy for tackling mpox in the Democratic Republic of the Congo
View
ASRA Pain Medicine release groundbreaking new surgical infection prevention guidelines
View
The HIV vaccine race: Challenges and breakthroughs with Dr Amesika Nyaku
View
CROI 2025: The countdown is on!
View
Poliovirus rise in Europe: A persistent threat despite eradication efforts
View
Lenacapavir achieves 100% efficacy in landmark HIV prevention trial
View
Glecaprevir/Pibrentasvir approved for acute hepatitis C: A new era for early intervention
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup